Bank of Nova Scotia’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-131,414
Closed -$10.5M 963
2016
Q4
$10.5M Buy
131,414
+660
+0.5% +$52.4K 0.05% 191
2016
Q3
$10.4M Buy
130,754
+125,100
+2,213% +$10.1M 0.06% 160
2016
Q2
$441K Buy
5,654
+380
+7% +$27.1K ﹤0.01% 519
2016
Q1
$290K Buy
5,274
+60
+1% +$3.27K ﹤0.01% 590
2015
Q4
$322K Buy
5,214
+20
+0.4% +$1.26K ﹤0.01% 593
2015
Q3
$328K Buy
5,194
+190
+4% +$13.6K ﹤0.01% 519
2015
Q2
$366K Buy
5,004
+160
+3% +$11.6K ﹤0.01% 428
2015
Q1
$317K Sell
4,844
-82
-2% -$5.45K ﹤0.01% 471
2014
Q4
$320K Buy
4,926
+500
+11% +$32.2K ﹤0.01% 451
2014
Q3
$266K Hold
4,426
﹤0.01% 475
2014
Q2
$307K Buy
4,426
+119
+3% +$7.71K ﹤0.01% 438
2014
Q1
$282K Sell
4,307
-4
-0.1% -$260 ﹤0.01% 475
2013
Q4
$267K Buy
4,311
+477
+12% +$27.6K ﹤0.01% 487
2013
Q3
$206K Sell
3,834
-589
-13% -$30.3K ﹤0.01% 495
2013
Q2
$202K Buy
+4,423
New +$192K ﹤0.01% 475

Other funds holding STJ

Bank of Nova Scotia's STJ Position: Q1 2017 in Review

Bank of Nova Scotia sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 131,414 shares — an estimated $10.5M sold.

Bank of Nova Scotia first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $10.5M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Bank of Nova Scotia reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Bank of Nova Scotia sold 131,414 St Jude Medical shares in Q1 2017, an estimated $10.5M.
  • Bank of Nova Scotia first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Bank of Nova Scotia's St Jude Medical position peaked at $10.5M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bank of Nova Scotia's 13F filing for Q1 2017, filed 15 May 2017.